Related Experiment Video
Updated: Feb 9, 2026

Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion
Published on: August 29, 2018
Indirubin inhibits cell proliferation, migration, invasion and angiogenesis in tumor-derived endothelial cells
Zhuohong Li1, Chaofu Zhu1, Baiping An1
1Department of Oncology, The Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Purpose:
Hepatocellular carcinoma is one of the most predominant malignancies with high fatality rate and its incidence is rising at an alarming rate because of its resistance to radio- and chemotherapy. Indirubin is the major active anti-tumor ingredient of a traditional Chinese herbal medicine. The present study aimed to analyze the effects of indirubin on cell proliferation, migration, invasion, and angiogenesis of tumor-derived endothelial cells (Td-EC).
Methods:
Td-EC were derived from human umbilical vein endothelial cells (HUVEC) by treating HUVEC with the conditioned medium of human liver cancer cell line HepG2. Cell proliferation, migration, invasion, and angiogenesis were assessed by MTT, wound healing, in vitro cell invasion, and in vitro tube formation assay.
Results:
Td-EC were successfully obtained from HUVEC cultured with 50% culture supernatant from serum-starved HepG2 cells. Indirubin significantly inhibited Td-EC proliferation in a dose- and time-dependent manner. Indirubin also inhibited Td-EC migration, invasion, and angiogenesis. However, indirubin's effects were weaker on HUVEC than Td-EC.
Conclusion:
Indirubin significantly inhibited Td-EC proliferation, migration, invasion, and angiogenesis.
Insights
Indirubin, a compound from traditional Chinese medicine, effectively inhibits the proliferation, migration, invasion, and angiogenesis of tumor-derived endothelial cells (Td-EC). This suggests potential for new hepatocellular carcinoma treatments.
Area of Science:
- Oncology
- Pharmacology
- Cell Biology
Background:
- Hepatocellular carcinoma (HCC) is a prevalent malignancy with increasing incidence and high mortality.
- HCC exhibits resistance to conventional radio- and chemotherapy.
- Indirubin, a key component of traditional Chinese herbal medicine, possesses anti-tumor properties.
Purpose of the Study:
- To investigate the anti-cancer effects of indirubin on tumor-derived endothelial cells (Td-EC).
- To analyze indirubin's impact on Td-EC proliferation, migration, invasion, and angiogenesis.
- To compare indirubin's efficacy on Td-EC versus normal human umbilical vein endothelial cells (HUVEC).
Main Methods:
- Td-EC were generated from HUVEC using conditioned medium from the HepG2 human liver cancer cell line.
- Cell proliferation was measured using the MTT assay.
- Migration, invasion, and angiogenesis were assessed via wound healing, in vitro invasion, and in vitro tube formation assays, respectively.
Main Results:
- Successful derivation of Td-EC was confirmed.
- Indirubin demonstrated significant dose- and time-dependent inhibition of Td-EC proliferation.
- Indirubin markedly suppressed Td-EC migration, invasion, and angiogenesis, with stronger effects compared to HUVEC.
Conclusions:
- Indirubin exhibits potent inhibitory effects on Td-EC proliferation, migration, invasion, and angiogenesis.
- These findings highlight indirubin's potential as a therapeutic agent against hepatocellular carcinoma by targeting tumor angiogenesis and metastasis.
More Related Videos
Related Concept Videos
Cell Migration
Cell Migration
Cells Coordinate Growth and Proliferation
Cancer Cell Migration through Invadopodia
Chemotaxis and Direction of Cell Migration
Role of Myosin in Cell Migration
Myosin II is a hexamer comprising two heavy chains with globular heads and coiled-coil tails, two regulatory light chains, and two essential light chains. The ATPase sites on the myosin heads hydrolyze ATP, and the released phosphate generates the force for contraction....

